6 hasil untuk "Adith Mohan"
Menampilkan 1–6 · 0,73 detik · RSS
-
Artikel Jurnal Teks lengkap
Deep Brain Stimulation of the Antero-Medial Globus Pallidus Interna for Tourette Syndrome
Background: We have previously reported the results of Deep Brain Stimulation (DBS) of the antero-medial globus pallidus interna (GPi) for severe Tourette Syndrome (TS) in 11 patients. We extend this case series to 17 patients and a longer follow-up to a maximum of 46 months. Methods: 17 patients…
Juga tersedia di: DOAJ
-
Artikel Jurnal
Case report: Down syndrome regression disorder, catatonia, and psychiatric and immunomodulatory interventions
Down syndrome regression disorder (DSRD) is a rare condition involving subacute cognitive decline, loss of previously acquired developmental skills, and prominent neuropsychiatric symptoms, particularly catatonia, in people with Down syndrome. It is thought to involve both autoimmune and…
-
Artikel Jurnal
Disability, distress and delayed access to care in functional neurological disorder: cross-sectional study from an Australian tertiary clinic
Background Functional neurological disorder (FND) is a common condition, but there remain substantial gaps in our understanding of its effects, particularly on severity of disability and health status. Aims To characterise disability, quality of life and psychological and somatic symptom…
-
Artikel Jurnal
A randomised, double-blind, sham-controlled trial of deep brain stimulation of the bed nucleus of the stria terminalis for treatment-resistant obsessive-compulsive disorder
Abstract Deep brain stimulation (DBS) is a promising treatment for severe, treatment-resistant obsessive-compulsive disorder (OCD). Here, nine participants (four females, mean age 47.9 ± 10.7 years) were implanted with DBS electrodes bilaterally in the bed nucleus of the stria terminalis (BNST)…
-
Artikel Jurnal
Medicinal cannabis for psychiatry-related conditions: an overview of current Australian prescribing
Objective: Evidence is accumulating that components of the Cannabis sativa plant may have therapeutic potential in treating psychiatric disorders. Medicinal cannabis (MC) products are legally available for prescription in Australia, primarily through the Therapeutic Goods Administration (TGA)…